BHC N Stock Overview
Operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Bausch Health Companies Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$200.19 |
| 52 Week High | US$200.19 |
| 52 Week Low | US$108.01 |
| Beta | 0.74 |
| 11 Month Change | 69.37% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -63.34% |
| 5 Year Change | -63.99% |
| Change since IPO | -88.37% |
Recent News & Updates
Recent updates
Shareholder Returns
| BHC N | MX Pharmaceuticals | MX Market | |
|---|---|---|---|
| 7D | 0% | -1.3% | -0.3% |
| 1Y | n/a | -19.3% | -4.0% |
Return vs Industry: Insufficient data to determine how BHC N performed against the MX Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how BHC N performed against the MX Market.
Price Volatility
| BHC N volatility | |
|---|---|
| BHC N Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 6.6% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in MX Market | 6.2% |
| 10% least volatile stocks in MX Market | 2.7% |
Stable Share Price: BHC N's share price has been volatile over the past 3 months compared to the MX market.
Volatility Over Time: Insufficient data to determine BHC N's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 20,270 | Tom Appio | www.bauschhealth.com |
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb.
Bausch Health Companies Inc. Fundamentals Summary
| BHC N fundamental statistics | |
|---|---|
| Market cap | Mex$60.04b |
| Earnings (TTM) | -Mex$3.65b |
| Revenue (TTM) | Mex$194.03b |
0.3x
P/S Ratio-16.5x
P/E RatioIs BHC N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BHC N income statement (TTM) | |
|---|---|
| Revenue | US$9.47b |
| Cost of Revenue | US$2.76b |
| Gross Profit | US$6.71b |
| Other Expenses | US$6.89b |
| Earnings | -US$178.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.48 |
| Gross Margin | 70.87% |
| Net Profit Margin | -1.88% |
| Debt/Equity Ratio | -8,887.2% |
How did BHC N perform over the long term?
See historical performance and comparison